PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Marx N et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. 2000 J. Immunol. pmid:10843708
Padilla J et al. PPAR-gamma-mediated regulation of normal and malignant B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818446
Padilla J et al. Effects of 15-deoxy-delta 12,14-PGJ2 on B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818475
Hwang SW et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10823958
Inoue H et al. Feedback control of cyclooxygenase-2 expression through PPARgamma. 2000 J. Biol. Chem. pmid:10827178
Saarinen JV et al. Release of histamine and leukotriene C4 in immediate allergic wheal reaction as measured with the microdialysis technique. 2000 Arch. Dermatol. Res. pmid:10966057
Miyahara T et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. 2000 J. Biol. Chem. pmid:10969082
Vanaja DK et al. Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. 2000 Cancer Res. pmid:10987274
Soler M et al. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. 2000 Circ. Res. pmid:10988243
Sakamoto H et al. Involvement of phospholipid hydroperoxide glutathione peroxidase in the modulation of prostaglandin D2 synthesis. 2000 J. Biol. Chem. pmid:11010961
Bamba H et al. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. 2000 Biochem. Biophys. Res. Commun. pmid:10873632
Ikeda U et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. 2000 Hypertension pmid:10856269
Ajuebor MN et al. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898767
Sugiyama H et al. Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. 2000 FEBS Lett. pmid:10675550
Matsuoka T et al. Prostaglandin D2 as a mediator of allergic asthma. 2000 Science pmid:10720327
Kubata BK et al. Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. 2000 J. Exp. Med. pmid:11067881
Takeda K et al. Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. 2000 Circulation pmid:11023940
Hamel L et al. Induction of heat shock protein 70 by herbimycin A and cyclopentenone prostaglandins in smooth muscle cells. 2000 Cell Stress Chaperones pmid:11147963
Li L et al. 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. 2001 J. Biol. Chem. pmid:11477100
Ahluwalia P et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. 2001 J. Allergy Clin. Immunol. pmid:11544467
Nicolaidis S et al. [Variations of hypothalamic and cortical prostaglandins and monoamines reveal transitions in arousal states: microdialysis study in the rat]. 2001 Rev. Neurol. (Paris) pmid:11924034
Keelan J et al. 15-deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11785780
Pignatelli M et al. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. 2001 J. Cell. Sci. pmid:11739643
Gervais FG et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. 2001 J. Allergy Clin. Immunol. pmid:11742277
Reilly TP et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. 2001 Chem. Res. Toxicol. pmid:11743745
Takeda K et al. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. 2001 J. Biol. Chem. pmid:11687581
Tanaka T et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. 2001 Life Sci. pmid:11693274
Niyonsaba F et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. 2001 Eur. J. Immunol. pmid:11298331
Harris SG and Phipps RP The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. 2001 Eur. J. Immunol. pmid:11298334
Tanaka H and Nagai H [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation]. 2001 Nippon Yakurigaku Zasshi pmid:11338375
Tomlinson JW et al. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. 2001 Endocrinology pmid:11316764
Thévenon C et al. Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. 2001 Clin. Chem. pmid:11274037
Rohn TT et al. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. 2001 Neuroreport pmid:11277593
Satoh T et al. Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. 2001 J. Neurochem. pmid:11279261
Drew PD and Chavis JA The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. 2001 J. Neuroimmunol. pmid:11282151
Guyton K et al. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. 2001 J. Leukoc. Biol. pmid:11310850
Govoni S et al. The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. 2001 Neurosci. Lett. pmid:11311500
Tsubouchi Y et al. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. 2001 Biochem. Biophys. Res. Commun. pmid:11350047
Wang C et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. 2001 Mol. Cell. Biol. pmid:11287611
Jiang JG et al. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. 2001 J. Biol. Chem. pmid:11292834
Serghides L and Kain KC Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. 2001 J. Immunol. pmid:11359831
Urquhart P et al. Profile of eicosanoids produced by human saphenous vein endothelial cells and the effect of dietary fatty acids. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11487303
Angeli V et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. 2001 J. Exp. Med. pmid:11369785
Krawiec ME et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. 2001 Am. J. Respir. Crit. Care Med. pmid:11371398
Saarinen JV et al. Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. 2001 Eur. J. Clin. Pharmacol. pmid:11372583
Buechler C et al. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. 2001 Biochim. Biophys. Acta pmid:11420178
VanderEnde DS and Morrow JD Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. 2001 J. Am. Acad. Dermatol. pmid:11423836
Park JM Role of prostaglandins in bladder smooth muscle cell gene expression. 2001 Urology pmid:11378068
Chang TS et al. NQ-Y15 inhibits the calcium mobilization by elevation of cyclic AMP in rat platelets. 2001 Biol. Pharm. Bull. pmid:11379764
Fajas L et al. PPAR gamma: an essential role in metabolic control. 2001 Nutr Metab Cardiovasc Dis pmid:11383325
Boutaud O et al. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid. 2001 Biochemistry pmid:11389610
Chen NG and Han X Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. 2001 Biochem. Biophys. Res. Commun. pmid:11401521
Lau HY and Chan CL Modulation of intracellular cyclic AMP in immunologically activated rat peritoneal mast cells by prostaglandin D2. 2001 Inflamm. Res. pmid:11411605
Serhan CN and Devchand PR Novel antiinflammatory targets for asthma. A role for PPARgamma? 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415929
Wang AC et al. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415933
Eto K et al. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. 2001 Eur. J. Pharmacol. pmid:11438300
Inoue T et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. 2001 Thromb. Haemost. pmid:11204569
Hirai H et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. 2001 J. Exp. Med. pmid:11208866
Guan Y et al. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. 2001 Am. J. Physiol. Renal Physiol. pmid:11704554
Bochenek G et al. [Prostaglandin D2: biosynthesis, biological properties and participation in bronchial asthma]. 2001 Pol. Arch. Med. Wewn. pmid:11928572
Azuma Y et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages. 2001 Biochem. Biophys. Res. Commun. pmid:11327705
Equils O et al. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. 2001 J. Immunol. pmid:11160291
Wilmer WA et al. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. 2001 Biochem. Biophys. Res. Commun. pmid:11178960
Kang SS et al. Cyclooxygenase-2 inhibitory cerebrosides from phytolaccae radix. 2001 Chem. Pharm. Bull. pmid:11253924
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Fahmi H et al. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. 2001 Arthritis Rheum. pmid:11263774
Hsieh FH et al. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. 2001 J. Exp. Med. pmid:11136826
Tunaz H et al. Prostaglandin biosynthesis by fat body from true armyworms, Pseudaletia unipuncta. 2001 Insect Biochem. Mol. Biol. pmid:11222953
Person EC et al. Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo. 2001 Endocrinology pmid:11159824
Reilly CM et al. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. 2001 Clin. Immunol. pmid:11237557
Kitamura Y et al. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. 2001 Eur. J. Pharmacol. pmid:11164379
Kadekaro M et al. Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats. 2001 Brain Res. pmid:11166690
Szczeklik A et al. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. 2001 Clin. Exp. Allergy pmid:11251623
Nielsen PN et al. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. 2001 Clin. Exp. Allergy pmid:11591187
Satoh K et al. Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in rat liver on admistration via the portal vein. 2001 Mutat. Res. pmid:11600134
Kitatani K et al. Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. 2001 Arch. Biochem. Biophys. pmid:11697858
Levonen AL et al. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11701476
Ianaro A et al. Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. 2001 FEBS Lett. pmid:11707269
Azuma Y et al. 15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions. 2001 Int. Immunopharmacol. pmid:11710539
Robbins IM et al. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. 2001 Chest pmid:11713147
Jozkowicz A et al. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner. 2001 Prostaglandins Other Lipid Mediat. pmid:11577781
Garcia Palacios V et al. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728175
Levine L Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728177
Tanimoto A et al. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. 2001 FEBS Lett. pmid:11728449
Yamamoto K et al. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. 2001 Circulation pmid:11581147
Mizoguchi A et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11562489
Inoue K et al. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. 2001 Biochem. Biophys. Res. Commun. pmid:11563856
Clay CE et al. Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells. 2001 J. Biol. Chem. pmid:11668172
Monneret G et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. 2001 Blood pmid:11535533
Akrishnan VR and Menon VP Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats. 2001 Cell Biol. Toxicol. pmid:11504446
Chiba Y et al. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells. 2001 Biochem. Biophys. Res. Commun. pmid:11511093
Kozawa O et al. Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. 2001 Cell. Signal. pmid:11483406
Nakashiro KI et al. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. 2001 Am. J. Pathol. pmid:11485917
Takashima T et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. 2001 Int. J. Oncol. pmid:11494023
Rovin BH et al. Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. 2001 J. Am. Soc. Nephrol. pmid:11461938
Cernuda-Morollón E et al. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. 2001 J. Biol. Chem. pmid:11466314
Boyault S et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. 2001 FEBS Lett. pmid:11457450
Nishimura H et al. Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. 2001 Prostaglandins Other Lipid Mediat. pmid:11519790
Clay CE et al. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. 2001 J. Investig. Med. pmid:11523697
Hunter JG et al. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways. 2001 J. Biol. Chem. pmid:11477074